DHIVE Talks

 
 

Long Covid & Lyme

Survivor Corps Long Covid Platform + Q&A

Diana Berrent | Founder of Survivor Corps; June 9th, 2022

Insights on diagnostic commercialization and Tick-Borne Disease marketplace from Galaxy Diagnostics'

Amanda Elam, PhD, CEO/Cofounder, Galaxy Diagnostics; June 8th, 2022

Long Covid Update and Q&A with Dr. Jason Maley

Jason Maley, MD | Director of Beth Israel DMC Critical Illness and COVID-19 Survivorship Program; January 19th, 2022

Preventing Lyme Disease and other Tick Borne Diseases

Alexis Chesney, MS, ND, LAc | Founder of the Naturopathic Medical Student Association; January 12th, 2022

Latest on Lyme and Q&A with Prof. Ahern and Tammy Crawford

Holly Ahern | Prof. of microbiology at the State University of New York at Adirondack and Tammy Crawford | Founder, Executive Director. Focus On Lyme; January 10th, 2022

Chronic Lyme & Long Covid, Shared Perspectives

Dr. Steven Philips; July 30th, 2021

Similarities of Long COVID and Lyme disease: Future Research Opportunities

Dr. Richard Horowitz, medical director of the Hudson Valley Healing Arts Center; June 28th, 2021

The Evasive and Persistent Lyme Disease Spirochete

Dr. Monica Embers, Associate Professor in the Division of Immunology and the Director of Vector-borne Disease Research at Tulane University; June 22nd, 2021

Lyme Disease Biobank: Challenges and Opportunities in Building a Representative, Real-world Collection

Dr. Liz Horn, Co-founder of Lyme Disease BioBank; June 21st, 2021

Applying Healthcare Delivery Science to Long COVID: Lessons from a Multidisciplinary Clinical Program


Dr. Jason Maley, Physician and Director @Beth Israel Deaconess Medical Center (BIDMC) Critical Illness and COVID-19 Survivorship Program; June 21st, 2021

Lyme Disease Surveillance & Research in the Information Age: Opportunities and Challenges

Alison Hinckley, PhD, Lead for the Epidemiology and Surveillance Team, Centers for Disease Control and Prevention (CDC); June 17th, 2021

Epidemiology and Pathobiology of Lyme Disease: Challenges and Opportunities for Innovation

Holly Ahern, Professor of Microbiology at the State University of New York at Adirondack; June 16th, 2021


IBD

Session with Professor Eric Alm

Eric Alm, PhD | Professor of Biological Engineering, MIT | Co-Director for the Center of Microbiome Informatics and Therapeutics at MIT; June 7th, 2022

Count Me In: Partnering with Patients to Accelerate the Pace of Cancer Discoveries

Corrie Painter, PhD | Associate Director of Operations and Scientific Outreach, Cancer Program, Broad Institute | Associate Director, Count Me In; January 14th, 2022


GutSee: Building an engaging user experience for patients in a longitudinal IBD study

Ben Cooley, Duyen Nguyen, and Andrew Tang | Pattern, The Broad Institute of MIT and Harvard; January 13th, 2022


IBD Tracker: identifying biomarkers in the gut microbiome predictive of an IBD flare

Marjolein A.Y. Klaassen | University of Groningen and University Medical Center of Groningen; January 12th, 2022


Monitoring an IBD patient in remission

Jason Zhang, MD | Clinical Fellow in Pediatrics | Boston Children's Hospital; January 12th, 2022


The Complexities of Clinical Research: We’re Only Human!

Helena Lau, MSPH & Sean Kim | The Xavier Lab at MGH and the Broad Institute | the MGH Crohn's and Colitis Center; January 11th, 2022


Diagnostic and therapeutic opportunities in inflammatory bowel disease

Sathish Subramanian, MD, PhD | Gasteroentrenology Fellow | MGH; January 11th, 2022


CMIT and the IBD Tracker Trial

Eric Alm, PhD | Professor of Biological Engineering, MIT | Co-Director for the Center of Microbiome Informatics and Therapeutics at MIT; January 10th, 2022

Down Syndrome

Developments in Down syndrome and the Impact on Achieving One’s Potential

Linda Patel, PsyD, Assistant Professor | Department of Psychiatry | University of Colorado School of Medicine; January 13th, 2022


The Evolving Landscape of Down Syndrome Associated Alzheimer’s Disease

James Hendrix & Hampus Hillerstrom | CSO and CEO of LuMind; January 12th, 2022


Weight Management and Associated Conditions in Down Syndrome

Nicolas Oreskovic, MD, MPH | Medical Director, iCMP, MGH; January 11th, 2022

Improving Health Care Maintenance in Down Syndrome

Stephanie L. Santoro, M.D. | Director of Quality Improvement Research, MGH Down Syndrome Program; January 11th, 2022

Down Syndrome: Meeting Medical and Developmental Needs

Nicole Baumer, MD, MEd | Director of Boston Children's Hospital Down Syndrome Program; January 10th, 2022


Catalyst

The Current State of the Opioid Crisis and it’s impacts on Communities, Pre-Hospital, and Emergency Medicine

Kieran Warner, MD, Lyen C. Huang, MD, MPH, FACS, FASCRS​ | Assistant Professor of Surgery | Adjunct Assistant Professor | University of Utah School of Medicine, Bahar Aliakbarian, PhD | R&D Director | Research Associate Professor – The Axia Institute | Michigan State University; June 9th, 2022

Current Best Practices for Medication Administration Documentation in the Emergency Department

Melonie Abravanel-Wright, RN | Emergency department registered nurse, University of Utah Health Sciences; June 8th, 2022

STI and Unplanned Pregnancy Prevention

Bidia Deperthes | Sexual Health Team Lead and HIV Advisor, United Nations Population Fund; Stacy Chin PhD | Gates Grand Challenge Awardee, CEO HydroGlyde Coatings; Ravi Rasalingam; and Tarsha Ward; June 7th, 2022